This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer: How Perfect Stocks Morph Into Lemons

Then there's AMN Healthcare Services (AHS - Get Report), a $600 million company that's a one-stop shop for all of the staffing needs for hospitals -- a terrific story that should get better with age as we go into Obamacare and more and more people become elderly because of the nation's changing demographics. This is a terrific little company that's the largest in its industry with a very bright CEO, Susan Salka, and an even brighter future.

Many businesses will be challenged by Obamacare, but hospitals are not one of them -- and when they need doctors or nurses and don't want to put them on full staff, they will call AMN Healthcare. I found myself wondering why this stock's market capitalization is only at $600 million, as this company's total addressable market is huge and it's recognized as best in class in the industry.

But then I thought about it and recognized that, with a tougher market, no big mutual fund is going to want to get trapped in a junior growth stock with no place to go if things go wrong. Stocks like AMN are magic-carpet rides until they become roach motels when the tape morphs from glorious to toxic.

Salesforce.com, a cloud play; Radian, a housing play; and AMN, a healthcare play: These stocks were all perfect just a few weeks ago. Now they're facing challenges as the buyers reassess their commitments and sellers ring the register.

At the time of publication, Action Alerts PLUS, which Cramer co-manages as a charitable trust, had no positions in the stocks mentioned.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Markets

Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Our Tweets

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs